ScreenPoint Medical locks in $28m Series C

Netherlands-based ScreenPoint Medical, an AI technology company focused on early detection of breast cancer, has raised $28 million in Series C funding.

28 July 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles